Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A.M. Mulligan

Testing for HER2 in Breast Cancer: Current Pathology Challenges Faced in Canada

Current Oncology
Oncology
2012English

Related publications

Current Neoadjuvant Treatment Options for HER2 Positive Breast Cancer

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2011English

Breast Cancer Stem Cells in HER2-negative Breast Cancer Cells Contribute to HER2-mediated Radioresistance and Molecular Subtype Conversion: Clinical Implications for Serum HER2 in Recurrent HER2-negative Breast Cancer

Oncotarget
Oncology
2017English

Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study

European Journal of Breast Health
2018English

ID3014 Evaluation of HER2 Status in Breast Cancer: Current Status and Future Directions

Biomedical Research and Therapy
BiochemistryMedicineGeneticsMolecular Biology
2017English

Current Approaches and Future Directions in the Treatment of HER2-positive Breast Cancer

Cancer Treatment Reviews
MedicineOncologyRadiologyNuclear MedicineImaging
2013English

HER2 Expression in NF1 Breast Cancer—Response

Cancer Prevention Research
MedicineCancer ResearchOncology
2019English

Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer

Frontiers in Oncology
Cancer ResearchOncology
2018English

Commentary: Hormone Receptor Testing in Breast Cancer: A Distress Signal From Canada

Oncologist
Cancer ResearchMedicineOncology
2008English

Targeted Therapy for HER2 Positive Breast Cancer

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy